SSWM
ABMD

Sheets Smith Wealth Management’s Abiomed Inc ABMD Stock Holding History

Sheets Smith Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,516
Closed -$1.13M – 332
2018
Q3 		$1.13M Sell
2,516
-3,468
-58% -$1.37M 0.23% 105
2018
Q2 		$2.45M Buy
5,984
+86
+1% +$31.2K 0.57% 48
2018
Q1 		$1.72M Sell
5,898
-63
-1% -$16K 0.41% 65
2017
Q4 		$1.12M Buy
5,961
+87
+1% +$16.2K 0.26% 108
2017
Q3 		$990K Buy
5,874
+3,625
+161% +$548K 0.25% 111
2017
Q2 		$322K Buy
+2,249
New +$302K 0.09% 217

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sheets Smith Wealth Management's ABMD Position: Q4 2018 in Review

Sheets Smith Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 2,516 shares — an estimated $1.13M sold.

Sheets Smith Wealth Management first reported a position in ABMD in Q2 2017 and held it in 6 quarters. The position peaked at $2.45M in Q2 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Sheets Smith Wealth Management reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 2,516 Abiomed Inc shares in Q4 2018, an estimated $1.13M.
  • Sheets Smith Wealth Management first reported a position in Abiomed Inc in Q2 2017 and held it in 6 quarters.
  • Sheets Smith Wealth Management's Abiomed Inc position peaked at $2.45M in Q2 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Sheets Smith Wealth Management's 13F filing for Q4 2018, filed 11 Jan 2019.